| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,123 |
12,866 |
$912K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,519 |
7,043 |
$346K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,715 |
4,477 |
$55K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,031 |
1,003 |
$54K |
| 90691 |
|
527 |
521 |
$50K |
| 36415 |
Collection of venous blood by venipuncture |
11,454 |
10,666 |
$42K |
| 90717 |
|
196 |
194 |
$23K |
| 99401 |
|
763 |
760 |
$20K |
| 80061 |
Lipid panel |
1,604 |
1,579 |
$19K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
280 |
271 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
216 |
211 |
$17K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,287 |
1,251 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,913 |
1,879 |
$15K |
| 80053 |
Comprehensive metabolic panel |
1,619 |
1,569 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
969 |
945 |
$12K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
112 |
107 |
$9K |
| 90686 |
|
1,279 |
1,243 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
282 |
277 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
65 |
65 |
$6K |
| 91320 |
|
76 |
66 |
$6K |
| 86803 |
|
391 |
382 |
$5K |
| 85027 |
|
945 |
924 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
202 |
198 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
63 |
62 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
700 |
656 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
573 |
546 |
$4K |
| X5622 |
|
419 |
417 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
51 |
51 |
$3K |
| 99402 |
|
74 |
73 |
$3K |
| 92551 |
|
568 |
556 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
161 |
151 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
139 |
135 |
$3K |
| 90682 |
|
68 |
68 |
$2K |
| 96127 |
|
704 |
681 |
$2K |
| 99442 |
|
94 |
52 |
$2K |
| 0071A |
|
55 |
52 |
$2K |
| 90480 |
|
70 |
66 |
$2K |
| 99441 |
|
147 |
79 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
14 |
$2K |
| 0072A |
|
35 |
33 |
$1K |
| 90715 |
|
84 |
83 |
$1K |
| 0004A |
|
29 |
29 |
$1K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
40 |
40 |
$1K |
| 90632 |
|
16 |
16 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
164 |
159 |
$1K |
| 0054A |
|
27 |
27 |
$972.63 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
24 |
24 |
$958.17 |
| 90619 |
|
19 |
18 |
$708.45 |
| 99173 |
|
583 |
572 |
$588.20 |
| 90662 |
|
14 |
14 |
$575.75 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
216 |
210 |
$574.05 |
| G0008 |
Administration of influenza virus vaccine |
98 |
97 |
$460.50 |
| 82043 |
|
108 |
106 |
$457.15 |
| 99000 |
|
54 |
50 |
$444.00 |
| 90651 |
|
31 |
31 |
$440.82 |
| 99188 |
|
47 |
47 |
$345.11 |
| 85610 |
|
77 |
49 |
$338.45 |
| 82728 |
|
25 |
25 |
$335.18 |
| 90734 |
|
36 |
36 |
$217.32 |
| 81001 |
|
111 |
103 |
$163.06 |
| 90656 |
|
14 |
13 |
$109.98 |
| 87081 |
|
75 |
71 |
$93.48 |
| 99421 |
|
41 |
38 |
$88.65 |
| 87210 |
|
69 |
64 |
$85.95 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20 |
20 |
$63.06 |
| 36416 |
|
21 |
14 |
$60.44 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
12 |
$0.00 |